Principal Financial Group Inc Anavex Life Sciences Corp. Transaction History

Principal Financial Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$3.39 - $5.02 $33,506 - $49,617	-9,884 Reduced 46.42%	11,408 $48,000
Q1 2024 Apr 29, 2024	BUY	$4.55 - $6.75 $1,947 - $2,889	428 Added 2.05%	21,292 $108,000
Q4 2023 Feb 07, 2024	BUY	$5.04 - $9.95 $1,028 - $2,029	204 Added 0.99%	20,864 $194,000
Q3 2023 Nov 02, 2023	SELL	$6.55 - $9.37 $1,932 - $2,764	-295 Reduced 1.41%	20,660 $135,000
Q2 2023 Aug 07, 2023	BUY	$7.66 - $9.5 $12,945 - $16,055	1,690 Added 8.77%	20,955 $170,000
Q1 2023 May 09, 2023	SELL	$8.32 - $11.75 $11,972 - $16,908	-1,439 Reduced 6.95%	19,265 $165,000
Q4 2022 Feb 09, 2023	BUY	$7.65 - $14.43 $15,009 - $28,311	1,962 Added 10.47%	20,704 $191,000
Q3 2022 Nov 09, 2022	SELL	$8.9 - $12.86 $3,497 - $5,053	-393 Reduced 2.05%	18,742 $194,000
Q2 2022 Aug 10, 2022	BUY	$7.31 - $12.84 $50,095 - $87,992	6,853 Added 55.8%	19,135 $192,000
Q1 2022 May 09, 2022	BUY	$9.74 - $17.69 $8,512 - $15,461	874 Added 7.66%	12,282 $151,000
Q4 2021 Feb 09, 2022	SELL	$16.88 - $23.31 $266,535 - $368,064	-15,790 Reduced 58.06%	11,408 $198,000
Q3 2021 Nov 09, 2021	BUY	$16.82 - $25.75 $20,755 - $31,775	1,234 Added 4.75%	27,198 $488,000
Q2 2021 Aug 10, 2021	BUY	$10.16 - $28.86 $137,251 - $389,869	13,509 Added 108.46%	25,964 $593,000
Q1 2021 May 10, 2021	SELL	$5.17 - $16.13 $6,410 - $20,001	-1,240 Reduced 9.05%	12,455 $186,000
Q4 2020 Feb 08, 2021	BUY	$4.01 - $7.58 $54,916 - $103,808	13,695 New	13,695 $74,000

189

29.2M

894K

821K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $698M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.